Open Access
Vet. Res.
Volume 37, Number 5, September-October 2006
Page(s) 655 - 670
Published online 17 June 2006
How to cite this article Vet. Res. (2006) 655-670
References of  Vet. Res. 37 (2006) 655-670
  1. Anonymous, Introducing community measures for the control of classical swine fever, Council Directive 80/217/EEC, 1980.
  2. Balmelli C., Ruggli N., McCullough K., Summerfield A., Fibrocytes are potent stimulators of anti-virus cytotoxic T cells, J. Leukoc. Biol. 77 (2005) 923-933 [CrossRef] [PubMed].
  3. Brownlie J., The pathogenesis of bovine virus diarrhoea virus infections, Rev. Sci. Tech. 9 (1990) 43-59 [PubMed].
  4. Carrasco C.P., Rigden R.C., Schaffner R., Gerber H., Neuhaus V., Inumaru S., Takamatsu H., Bertoni G., McCullough K.C., Summerfield A., Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties, Immunology 104 (2001) 175-184 [PubMed].
  5. Carrasco C.P., Rigden R.C., Vincent I.E., Balmelli C., Ceppi M., Bauhofer O., Tache V., Hjertner B., McNeilly F., van Gennip H.G., McCullough K.C., Summerfield A., Interaction of classical swine fever virus with dendritic cells, J. Gen. Virol. 85 (2004) 1633-1641 [CrossRef] [PubMed].
  6. Depner K.R., Bouma A., Koenen F., Klinkenberg D., Lange E., deSmit H., Vanderhallen H., Classical swine fever (CSF) marker vaccine - Trial II. Challenge study in pregnant sows, Vet. Microbiol. 83 (2001) 107-120 [CrossRef] [PubMed].
  7. Dewulf J., Leavens H., Koenen F., Mintiens K., deKruif A., An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus, Vaccine 20 (2001) 86-91 [CrossRef] [PubMed].
  8. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A., Virus Taxonomy. VIIIth Report of the International Committee on Taxonomy of Viruses, Academic Press, San Diego, California, 2005.
  9. Floegel-Niesmann G., Classical swine fever (CSF) marker vaccine. Trial III - Evaluation of discriminatory ELISAs, Vet. Microbiol. 83 (2001) 121-136 [CrossRef] [PubMed].
  10. Goodbourn S., Didcock L., Randall R.E., Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures, J. Gen. Virol. 81 (2000) 2341-2364 [PubMed].
  11. Greiser-Wilke I., Dittmar K.E., Liess B., Moennig V., Heterogeneous expression of the non-structural protein p80/p125 in cells infected with different pestiviruses, J. Gen. Virol. 73 (1992) 47-52 [PubMed].
  12. Greiser-Wilke I., Moennig V., Vaccination against classical swine fever virus: limitations and new strategies, Anim. Health Res. Rev. 5 (2004) 223-226 [CrossRef] [PubMed].
  13. Hofmann M.A., Construction of an infectious chimeric classical swine fever virus containing the 5'UTR of bovine viral diarrhea virus, and its application as a universal internal positive control in real-time RT- PCR, J. Virol. Methods 114 (2003) 77-90 [CrossRef] [PubMed].
  14. Janeway C.A., Traver P., Walport M., Shlochik M., Immunobiology, Garland Publishing, New York and London, 2001.
  15. Kaden V., The situation of classical swine fever in wild boars in the European community and selected aspects of disease transmission, Berl. Munch. Tierarztl. Wochenschr. 111 (1998) 201-207 [PubMed].
  16. Maurer R., Stettler P., Ruggli N., Hofmann M.A., Tratschin J.D., Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV, Vaccine 23 (2005) 3318-3328 [CrossRef] [PubMed].
  17. Mittelholzer C., Moser C., Tratschin J.D., Hofmann M.A., Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains, Vet. Microbiol. 74 (2000) 293-308 [CrossRef] [PubMed].
  18. Moennig V., Introduction to classical swine fever: virus, disease and control policy, Vet. Microbiol. 73 (2000) 93-102 [CrossRef] [PubMed].
  19. Moormann R.J., Bouma A., Kramps J.A., Terpstra C., De Smit H.J., Development of a classical swine fever subunit marker vaccine and companion diagnostic test, Vet. Microbiol. 73 (2000) 209-219 [CrossRef] [PubMed].
  20. Moran T.P., Collier M., McKinnon K.P., Davis N.L., Johnston R.E., Serody J.S., A novel viral system for generating antigen-specific T cells, J. Immunol. 175 (2005) 3431-3438 [PubMed].
  21. Moser C., Ruggli N., Tratschin J.D., Hofmann M.A., Detection of antibodies against classical swine fever virus in swine sera by indirect ELISA using recombinant envelope glycoprotein E2, Vet. Microbiol. 51 (1996) 41-53 [CrossRef] [PubMed].
  22. Moser C., Stettler P., Tratschin J.D., Hofmann M.A., Cytopathogenic and noncytopathogenic RNA replicons of classical swine fever virus, J. Virol. 73 (1999) 7787-7794 [PubMed].
  23. Publicover J., Ramsburg E., Rose J.K., A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector, J. Virol. 79 (2005) 13231-13238 [CrossRef] [PubMed].
  24. Racanelli V., Behrens S.E., Aliberti J., Rehermann B., Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity, Immunity 20 (2004) 47-58 [CrossRef] [PubMed].
  25. Ruggli N., Tratschin J.D., Mittelholzer C., Hofmann M.A., Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J. Virol. 70 (1996) 3478-3487 [PubMed].
  26. Rumenapf T., Unger G., Strauss J.H., Thiel H.J., Processing of the envelope glycoproteins of pestiviruses, J. Virol. 67 (1993) 3288-3294 [PubMed].
  27. Stegeman A., Elbers A., deSmit H., Moser H., Smak J., Pluimers F., The 1997-1998 epidemic of classical swine fever in the Netherlands, Vet. Microbiol. 73 (2000) 183-196 [CrossRef] [PubMed].
  28. Terpstra C., Bloemraad M., Gielkens A.L., The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus, Vet. Microbiol. 9 (1984) 113-120 [CrossRef] [PubMed].
  29. Terpstra C., Wensvoort G., The protective value of vaccine induced neutralizing antibody titres in swine fever, Vet. Microbiol. 16 (1988) 123-128 [CrossRef] [PubMed].
  30. Toka F.N., Pack C.D., Rouse B.T., Molecular adjuvants for mucosal immunity, Immunol. Rev. 199 (2004) 100-112 [PubMed].
  31. Uttenthal A., LePotier M.F., Romero L., DeMia G.M., Floegel-Niesmann G., Classical swine fever (CSF) marker vaccine - Trial I. Challenge studies in weaner pigs, Vet. Microbiol. 83 (2001) 85-106 [CrossRef] [PubMed].
  32. Van Gennip H.G., Bouma A., van Rijn P.A., Widjojoatmodjo M.N., Moormann R.J., Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV, Vaccine 20 (2002) 1544-1556 [CrossRef] [PubMed].
  33. Van Oirschot J.T., Diva vaccines that reduce virus transmission, J. Biotechnol. 73 (1999) 195-205 [CrossRef] [PubMed].
  34. Van Oirschot J.T., Vaccinology of classical swine fever: from lab to field, Vet. Microbiol. 96 (2003) 367-384 [CrossRef] [PubMed].
  35. Weiland E., Stark R., Haas B., Rumenapf T., Meyers G., Thiel H.J., Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer, J. Virol. 64 (1990) 3563-3569 [PubMed].
  36. Weiland E., Ahl R., Stark R., Weiland F., Thiel H.J., A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus, J. Virol. 66 (1992) 3677-3682 [PubMed].
  37. Widjojoatmodjo M.N., van Gennip H.G., Bouma A., van Rijn P.A., Moormann R.J., Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines, J. Virol. 74 (2000) 2973-2980 [CrossRef] [PubMed].